연구성과로 돌아가기
2023 연구성과별 연구자 정보 (1807 / 2675)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Pharmacokinetic modulation of substrate drugs via the inhibition of drug-metabolizing enzymes and transporters using pharmaceutical excipients | Choi, Min-Koo | Choi, MK | 1 | Dankook Univ, Coll Pharm, Cheonan 31116, South Korea | isssong@knu.ac.kr; | |||||
| Pharmacokinetic modulation of substrate drugs via the inhibition of drug-metabolizing enzymes and transporters using pharmaceutical excipients | Lee, Jihoon | Lee, J | 2 | Kyungpook Natl Univ, Res Inst Pharmaceut Sci, Coll Pharm, Vessel Organ Interact Res Ctr VOICE,BK21 FOUR Comm, Daegu 41566, South Korea | isssong@knu.ac.kr; | |||||
| Pharmacokinetic modulation of substrate drugs via the inhibition of drug-metabolizing enzymes and transporters using pharmaceutical excipients | Song, Im-Sook | Song, IS | 3 | 교신저자 | Kyungpook Natl Univ, Res Inst Pharmaceut Sci, Coll Pharm, Vessel Organ Interact Res Ctr VOICE,BK21 FOUR Comm, Daegu 41566, South Korea | 0000-0002-4564-709X | Song, Im-Sook | isssong@knu.ac.kr; | ||
| Pharmacokinetic-pharmacodynamic integration of lincomycin against Actinobacillus pleuropneumoniae in swine | Lee, E. B. | Lee, EB | 1 | 교신저자 | Kyungpook Natl Univ, Cardiovasc Res Inst, Coll Vet Med, Lab Vet Pharmacokinet & Pharmacodynam, Daegu, South Korea | |||||
| Pharmacokinetic-pharmacodynamic integration of lincomycin against Actinobacillus pleuropneumoniae in swine | Park, S. C. | Park, SC | 2 | Kyungpook Natl Univ, Cardiovasc Res Inst, Coll Vet Med, Lab Vet Pharmacokinet & Pharmacodynam, Daegu, South Korea | AAT-3439-2021 | Park, Chang | ||||
| PHASE 1b/2a STUDY OF HETEROLOGOUS ChAdOx1-HBV/MVA-HBV THERAPEUTIC VACCINATION (VTP-300) COMBINED WITH LOW-DOSE NIVOLUMAB (LDN) IN VIRALLY-SUPPRESSED PATIENTS WITH CHB ON NUCLEOS(T)IDE ANALOGUES | Lim, Young-Suk | Lim, YS | 1 | Univ Ulsan, Dept Gastroenterol, Asan Med Ctr, Coll Med, Seoul, South Korea | AFQ-5165-2022 | Lim, Young-Suk | ||||
| PHASE 1b/2a STUDY OF HETEROLOGOUS ChAdOx1-HBV/MVA-HBV THERAPEUTIC VACCINATION (VTP-300) COMBINED WITH LOW-DOSE NIVOLUMAB (LDN) IN VIRALLY-SUPPRESSED PATIENTS WITH CHB ON NUCLEOS(T)IDE ANALOGUES | Lim, Young-Suk | Lim, YS | 1 | Univ Ulsan, Ctr Liver, Asan Med Ctr, Coll Med, Seoul, South Korea | AFQ-5165-2022 | Lim, Young-Suk | ||||
| PHASE 1b/2a STUDY OF HETEROLOGOUS ChAdOx1-HBV/MVA-HBV THERAPEUTIC VACCINATION (VTP-300) COMBINED WITH LOW-DOSE NIVOLUMAB (LDN) IN VIRALLY-SUPPRESSED PATIENTS WITH CHB ON NUCLEOS(T)IDE ANALOGUES | Evans, Tom | Evans, T | 2 | Vaccitech, Clin Operat, Oxford, England | ||||||
| PHASE 1b/2a STUDY OF HETEROLOGOUS ChAdOx1-HBV/MVA-HBV THERAPEUTIC VACCINATION (VTP-300) COMBINED WITH LOW-DOSE NIVOLUMAB (LDN) IN VIRALLY-SUPPRESSED PATIENTS WITH CHB ON NUCLEOS(T)IDE ANALOGUES | Barnes, Eleanor | Barnes, E | 3 | Univ Oxford, Natl Inst Hlth Res, Biomed Res Ctr, Oxford, England | ||||||
| PHASE 1b/2a STUDY OF HETEROLOGOUS ChAdOx1-HBV/MVA-HBV THERAPEUTIC VACCINATION (VTP-300) COMBINED WITH LOW-DOSE NIVOLUMAB (LDN) IN VIRALLY-SUPPRESSED PATIENTS WITH CHB ON NUCLEOS(T)IDE ANALOGUES | Barnes, Eleanor | Barnes, E | 3 | Univ Oxford, Nuffield Dept Med, Oxford, England | ||||||
| PHASE 1b/2a STUDY OF HETEROLOGOUS ChAdOx1-HBV/MVA-HBV THERAPEUTIC VACCINATION (VTP-300) COMBINED WITH LOW-DOSE NIVOLUMAB (LDN) IN VIRALLY-SUPPRESSED PATIENTS WITH CHB ON NUCLEOS(T)IDE ANALOGUES | Mehta, Reena | Mehta, R | 4 | Vaccitech Plc, Clin Operat, Oxford, England | LFU-3952-2024 | Mehta, Reena | ||||
| PHASE 1b/2a STUDY OF HETEROLOGOUS ChAdOx1-HBV/MVA-HBV THERAPEUTIC VACCINATION (VTP-300) COMBINED WITH LOW-DOSE NIVOLUMAB (LDN) IN VIRALLY-SUPPRESSED PATIENTS WITH CHB ON NUCLEOS(T)IDE ANALOGUES | Bussey, Louise | Bussey, L | 5 | Vaccitech, Clin Operat, Oxford, England | ||||||
| PHASE 1b/2a STUDY OF HETEROLOGOUS ChAdOx1-HBV/MVA-HBV THERAPEUTIC VACCINATION (VTP-300) COMBINED WITH LOW-DOSE NIVOLUMAB (LDN) IN VIRALLY-SUPPRESSED PATIENTS WITH CHB ON NUCLEOS(T)IDE ANALOGUES | Anderson, Katie | Anderson, K | 6 | Vaccitech Plc, Immunol Res, Oxford, England | ||||||
| PHASE 1b/2a STUDY OF HETEROLOGOUS ChAdOx1-HBV/MVA-HBV THERAPEUTIC VACCINATION (VTP-300) COMBINED WITH LOW-DOSE NIVOLUMAB (LDN) IN VIRALLY-SUPPRESSED PATIENTS WITH CHB ON NUCLEOS(T)IDE ANALOGUES | Vardeu, Antonella | Vardeu, A | 7 | Vaccitech, Res, Oxford, England | ||||||
| PHASE 1b/2a STUDY OF HETEROLOGOUS ChAdOx1-HBV/MVA-HBV THERAPEUTIC VACCINATION (VTP-300) COMBINED WITH LOW-DOSE NIVOLUMAB (LDN) IN VIRALLY-SUPPRESSED PATIENTS WITH CHB ON NUCLEOS(T)IDE ANALOGUES | Brown, Anthony | Brown, A | 8 | Univ Oxford, Peter Medawar Bldg Pathogen Res, Oxford, England |
페이지 이동: